Nicholas Farinola

A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults

Antonios O. Aliprantis, Christine A. Shaw, Paul Griffin et al. · Human Vaccines & Immunotherapeutics · 2020 · 151 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects

Paul B. Eckburg, Troy Lister, Susannah M. Walpole et al. · Antimicrobial Agents and Chemotherapy · 2019 · 53 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Development and validation of the Medication Regimen Simplification Guide for Residential Aged CarE (MRS GRACE)

Esa Y. H. Chen, Janet K. Sluggett, Jenni Ilomäki et al. · Clinical Interventions in Aging · 2018 · 41 citations · Full text

Pharmacy, Clinical Pharmacy, Geriatric Pharmacy +16

Denosumab‐induced hypocalcaemia in high bone turnover states of malignancy and secondary hyperparathyroidism from renal failure

Nicholas Farinola, Yada Kanjanapan · Internal Medicine Journal · 2013 · 39 citations

Medicine, Endocrinology, Oncology +17

An observer-blind, randomised, placebo-controlled, phase 1, single ascending dose study of dengue monoclonal antibody in healthy adults in Australia

Bhagwat Gunale, Nicholas Farinola, Chandrashekhar D. Kamat et al. · The Lancet Infectious Diseases · 2024 · 25 citations

Pharmacy, Immunology, Infectious Diseases +5